Henney FDA Will Be "Open, Timely And Responsive," Nominee Says
Executive Summary
FDA under Jane Henney would be "open, timely and responsive," the commissioner nominee told the Senate Labor & Human Resources Committee Aug. 24.
You may also be interested in...
FDA Generic Biologics Policy May Be One Change Under McClellan
FDA Commissioner-designate Mark McClellan appears to be open to establishing a generic approval system for biological products
FDA Generic Biologics Policy May Be One Change Under McClellan
FDA Commissioner-designate Mark McClellan appears to be open to establishing a generic approval system for biological products
FDA, USP Should Set Generic Biologics Standards, Sen. Hatch Proposes
Generic biologics should be a priority issue for the next FDA commissioner, Sen. Orrin Hatch (R-Utah) says